[go: up one dir, main page]

PE20060481A1 - N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas - Google Patents

N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas

Info

Publication number
PE20060481A1
PE20060481A1 PE2005000751A PE2005000751A PE20060481A1 PE 20060481 A1 PE20060481 A1 PE 20060481A1 PE 2005000751 A PE2005000751 A PE 2005000751A PE 2005000751 A PE2005000751 A PE 2005000751A PE 20060481 A1 PE20060481 A1 PE 20060481A1
Authority
PE
Peru
Prior art keywords
alkylen
inhibitors
substitute
aryl
gamma
Prior art date
Application number
PE2005000751A
Other languages
English (en)
Inventor
Hubert B Josien
John W Clader
Thomas A Bara
Hongmei Li
Zhiqiang Zhao
Dmitri A Pissarnitski
Ruo Xu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20060481A1 publication Critical patent/PE20060481A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE A COMPUESTOS DE N-ARILSUFONILAMINAS HETEROCICLICAS DE FORMULA (I), EN DONDE L ES -O-, -N(R6)-, -S-, ENTRE OTROS; R1 ES ARILO O HETEROARILO SUSTITUIDO CON R7; R2 ES -(C0-C6)ALQUILEN-(C3-C6)CICLOALQUILEN-(C0-C6)ALQUILEN-X-C(O)-Y, -(C0-C6)ALQUILEN-(C3-C6)CICLOALQUILEN-(C0-C6)ALQUILEN-C(O)-Y, -(C3-C6)CICLOALQUILEN-(C1-C6)ALQUILEN-C(O)-Y, ENTRE OTROS, SUSTITUIDO EL ALQUILENO CON UNO O MAS HIDROXI; R3 ES ARILO, ALQUILO, CICLOALQUILO,HETEROARILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON R7; X ES -O-, -N(R6)-, ENTRE OTROS; Y ES -NR8R9, -N(R6)-(CH2)b-NR8R9-, ARILO, ENTRE OTROS; m Yn SON INDEPENDIENTEMENTE DE 0 A 2, SIEMPRE QUE m + n SEA 1 0 2. SON PREFERIDOS: ESTER 4-(4-CLORO-BENCENSULFONIL)-5-(3,5-DIFLUORO-FENIL)-MORFOLIN-3-IL-METILICO DEL ACIDO 4-(2-HIDROXI-ETIL)-PIPERAZIN-1-CARBOXILICO, ALFA-[1-[4-[(4-CLOROFENIL)SULFONIL]-5(r)-CICLOPROPIL-3(S)-MORFOLINIL]CICLOPROPIL]-BETA-OXO-3,8-DIAZABICICLO[3.2.1]OCTAN-3-ETANOL, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE LA GAMMA SECRETASA POR LO QUE SON UTILES EN EL TRATAMIENTO DEL ALZHEIMER
PE2005000751A 2004-06-30 2005-06-28 N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas PE20060481A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58401004P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
PE20060481A1 true PE20060481A1 (es) 2006-06-19

Family

ID=35783342

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000751A PE20060481A1 (es) 2004-06-30 2005-06-28 N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas

Country Status (13)

Country Link
US (3) US7763613B2 (es)
EP (1) EP1789404B1 (es)
JP (1) JP2008505100A (es)
CN (2) CN101048393A (es)
AR (1) AR050994A1 (es)
AT (1) ATE461926T1 (es)
CA (1) CA2570183A1 (es)
DE (1) DE602005020156D1 (es)
ES (1) ES2341560T3 (es)
MX (1) MX2007000040A (es)
PE (1) PE20060481A1 (es)
TW (1) TWI297270B (es)
WO (1) WO2006004880A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007207481B2 (en) * 2006-01-20 2012-08-23 Merck Sharp & Dohme Corp. Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
WO2007092435A2 (en) 2006-02-07 2007-08-16 Wyeth 11-beta hsd1 inhibitors
AU2007245435A1 (en) * 2006-04-26 2007-11-08 Merck & Co., Inc. Piperidines and related compounds for treatment of Alzheimer's disease
WO2007141029A1 (en) * 2006-06-08 2007-12-13 Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Specific protease inhibitors and their use in cancer therapy
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
SI2091948T1 (sl) 2006-11-30 2012-07-31 Probiodrug Ag Novi inhibitorji glutaminil ciklaze
EA200901140A1 (ru) 2007-03-01 2010-04-30 Пробиодруг Аг Новое применение ингибиторов глутаминилциклазы
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
EA017119B1 (ru) * 2007-10-19 2012-09-28 Янссен Фармацевтика, Н.В. МОДУЛЯТОРЫ АКТИВНОСТИ γ-СЕКРЕТАЗЫ ИЗ ГРУППЫ ПИПЕРИДИНИЛА И ПИПЕРАЗИНИЛА
CN102695546B (zh) 2009-09-11 2014-09-10 前体生物药物股份公司 作为谷氨酰胺酰环化酶抑制剂的杂环衍生物
US20110190269A1 (en) * 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
SG183229A1 (en) 2010-03-10 2012-09-27 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
DK3461819T3 (da) 2017-09-29 2020-08-10 Probiodrug Ag Inhibitorer af glutaminylcyklase
CN109705052B (zh) * 2019-01-25 2020-12-08 苏州大学 一种制备1,4-二氢噁嗪的方法
CN119060034A (zh) * 2024-09-02 2024-12-03 上海信诺维生物医药有限公司 一种含吡喃取代的吗啉类化合物的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04247081A (ja) 1991-02-01 1992-09-03 Takeda Chem Ind Ltd ５員複素環酸アミド類
US5646167A (en) * 1993-01-06 1997-07-08 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamix acids
JP3834663B2 (ja) * 1996-02-02 2006-10-18 株式会社デ・ウエスタン・セラピテクス研究所 イソキノリン誘導体及び医薬
IL140041A0 (en) * 1998-06-03 2002-02-10 Guilford Pharm Inc Multiple heteroatom containing heterocyclic ring compounds substituted with carboxylic acids and isosteres thereof
CN1348442A (zh) 1999-02-26 2002-05-08 默克公司 新的磺胺化合物及其应用
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
JP2001261657A (ja) * 2000-03-17 2001-09-26 Yamanouchi Pharmaceut Co Ltd シアノフェニル誘導体
CA2406652A1 (en) 2000-04-20 2001-11-01 Nps Allelix Corp. Aminopiperidines for use as glyt-1 inhibitors
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
KR20030029978A (ko) 2000-09-25 2003-04-16 액테리온 파마슈티칼 리미티드 말라리아에 유용한 치환된 아미노-아자-사이클로알칸
IL159848A0 (en) * 2001-08-03 2004-06-20 Schering Corp Novel gamma secretase inhibitors
WO2003013527A1 (en) * 2001-08-03 2003-02-20 Schering Corporation Sulfonamide derivatives as gamma secretase inhibitors
US20040171614A1 (en) 2002-02-06 2004-09-02 Schering-Plough Corporation Novel gamma secretase inhibitors
US7256186B2 (en) * 2002-02-06 2007-08-14 Schering Corporation Gamma secretase inhibitors
TW200302717A (en) 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
ES2308206T3 (es) 2003-05-13 2008-12-01 Schering Corporation N-arilsulfonilpiperidinas con fuentes como inhibidores de gamma-secretasa.
JP4247081B2 (ja) 2003-09-24 2009-04-02 三菱電機株式会社 レーザアニール装置のレーザビーム強度モニタ方法とレーザアニール装置
AU2005230681B2 (en) * 2004-04-05 2009-07-30 Schering Corporation Novel gamma secretase inhibitors
US20060035884A1 (en) * 2004-05-20 2006-02-16 Elan Pharmaceuticals, Inc. N-cyclic sulfonamido inhibitors of gamma secretase
AU2007207481B2 (en) * 2006-01-20 2012-08-23 Merck Sharp & Dohme Corp. Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors

Also Published As

Publication number Publication date
CN101048393A (zh) 2007-10-03
AR050994A1 (es) 2006-12-13
CN101602741A (zh) 2009-12-16
MX2007000040A (es) 2007-03-07
WO2006004880A2 (en) 2006-01-12
JP2008505100A (ja) 2008-02-21
US20060040936A1 (en) 2006-02-23
US7998958B2 (en) 2011-08-16
EP1789404A2 (en) 2007-05-30
US20100087425A1 (en) 2010-04-08
ES2341560T3 (es) 2010-06-22
TW200612928A (en) 2006-05-01
US20100093695A1 (en) 2010-04-15
WO2006004880A3 (en) 2007-03-08
DE602005020156D1 (de) 2010-05-06
HK1099300A1 (en) 2007-08-10
ATE461926T1 (de) 2010-04-15
TWI297270B (en) 2008-06-01
CA2570183A1 (en) 2006-01-12
EP1789404B1 (en) 2010-03-24
US7763613B2 (en) 2010-07-27

Similar Documents

Publication Publication Date Title
PE20060481A1 (es) N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas
PE20040589A1 (es) Tiazolidinonas y su preparacion como medicamentos
PE20050121A1 (es) Acidos tienil-hidroxamicos, sustituidos referidos a la actividad enzimatica de la histona desacetilasa
PE20110067A1 (es) Derivados de piperidina como inhibidores de renina
PE20090952A1 (es) Compuestos de pirazol moduladores de raf
PE20071321A1 (es) Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
PE20090183A1 (es) Derivados de 1-oxa-3,9-diaza-espiro-[5.5]undecan-2-ona como moduladores de ccr5
PE20091656A1 (es) Compuestos heterociclicos como inhibidores de la cinasa raf
NO20073729L (no) Heterocykliske forbindelser som CCR2B-antagonister
PE20060215A1 (es) 4-fenilamino-quinazolin-6-il-amidas
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20061123A1 (es) Derivados de amida como inhibidores de la hidrolasa de amida de acido graso
PE20081836A1 (es) Derivados de piperidina como inhibidores de la sintasa de acido graso
UY25904A1 (es) Sulfonamidas heterocíclicas inhibidoras de receptores de endotelina
PE20080843A1 (es) Inhibidores de renina y metodo para su utilizacion
PE20141120A1 (es) Compuestos heterociclicos
PE20060569A1 (es) Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
PE20140703A1 (es) Derivados de heteroarilo como moduladores de nachr alfa 7
PE20191757A1 (es) Compuestos heterociclicos utiles como inhibidores dobles de atx/ca
CL2011000159A1 (es) Compuestos derivados de 1,3-oxazin-2-ona, inhibidores de 11beta-hsd1; composicion farmaceutica que los comprende; y su uso en el tratamiento de la diabetes.
PE20141004A1 (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed